Results 31 to 40 of about 12,381 (205)

Standard Operating Procedure for In-house Preparation of 131 I-rituximab for Radioimmunotherapy of Non-Hodgkin′s Lymphoma

World Journal of Nuclear Medicine, 2012
A Standard Operating Procedure (SOP) has been formulated for in-house preparation, quality control, dispensing and administration of 131 I-rituximab appropriate for the safe, effective, radioimmunotherapy of non-Hodgkin lymphoma.
Matthew Pickford, J. Turner
doaj   +1 more source

Excitation functions of proton induced nuclear reactions on natW up to 40 MeV [PDF]

, 2007
Excitation functions for the production of the 181,182m,182g,183,184g,186Re and 183,184Ta radionuclides from proton bombardment on natural tungsten were measured using the stacked-foil activation technique for the proton energies up to 40 MeV. A new data
Akkermans, Atkins, Atkins, Bishayee, Blann, Ceolin, Dmitriev, Dmitriev, Filoosofov, Gilbert, Gilmore, Guinyun Kim, Hauser, Hermanne, Johnson, Kairemo, Kalbach, Kalbach, Khalid, Khandaker, Kinsey, Koning, Kormali, Kwangsoo Kim, Kyung-Sook Kim, Lintschinger, Loska, Manwoo Lee, Mathias, Mayeen Uddin Khandaker, Nakamaru, Siegel, Tolmachev, Uddin, Wang, Weisskopf, Weisskopf, Young Seok Lee, Young-Ouk Lee, Young-Sik Cho, Zimmerman   +40 more
core   +2 more sources

Pretargeted radioimmunotherapy: clinically more efficient than conventional radioimmunotherapy? [PDF]

European Journal of Nuclear Medicine and Molecular Imaging, 2013
The clinical efficacy of radioimmunotherapy (RIT) has been clearly documented in the consolidation situation, such as first-line treatment of indolent non-Hodgkin lymphoma after induction chemotherapy [1] or after salvage resection of liver metastases from colon carcinoma [2], when tumour targets have a small, preferably microscopic, size. Efficacy has
Caroline, Rousseau, Françoise, Kraeber-Bodéré, Jacques, Barbet, Jean-François, Chatal   +3 more
openaire   +2 more sources

Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity 86Y- or 177Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates [PDF]

, 2015
Purpose: GPA33 is a colorectal cancer (CRC) antigen with unique retention properties after huA33-mediated tumor targeting. We tested a pretargeted radioimmunotherapy (PRIT) approach for CRC using a tetravalent bispecific antibody with dual specificity ...
Carrasquillo, Jorge A., Chalasani, Sandhya, Cheal, Sarah M., Cheung, Nai-Kong V., Fung, Edward K., Guo, Hong-fen, Jungbluth, Achim, Larson, Steven M., Lee, Sang-gyu, O’Donoghue, Joseph, Punzalan, Blesida, Smith-Jones, Peter M., Wittrup, Karl Dane, Xu, Hong, Zanzonico, Pat B.   +14 more
core   +1 more source

Radiation-Induced Chromosomal Aberrations and Immunotherapy: Micronuclei, Cytosolic DNA, and Interferon-Production Pathway

Frontiers in Oncology, 2018
Radiation-induced chromosomal aberrations represent an early marker of late effects, including cell killing and transformation. The measurement of cytogenetic damage in tissues, generally in blood lymphocytes, from patients treated with radiotherapy has ...
Marco Durante, Silvia C. Formenti
doaj   +1 more source

Radioimmunotherapy Combined With Low-Intensity Ultrasound and Microbubbles: A Potential Novel Strategy for Treatment of Solid Tumors

Frontiers in Oncology, 2021
The prognosis of advanced malignant tumors is very poor, and effective treatment is limited. Radioimmunotherapy (RIT) is a novel treatment method. However, its anti-tumor effect is relatively low in solid tumors, which is mainly due to the blood-tumor ...
Binwei Lin, Huan Du, Jinjia Fan, Dan Huang, Feng Gao, Jie Li, Yu Zhang, Gang Feng, Tangzhi Dai, Xiaobo Du   +9 more
doaj   +1 more source

Re-188 Enhances the Inhibitory Effect of Bevacizumab in Non-Small-Cell Lung Cancer

Molecules, 2016
The malignant behaviors of solid tumors such as growth, infiltration and metastasis are mainly nourished by tumor neovascularization. Thus, anti-angiogenic therapy is key to controlling tumor progression.
Jie Xiao, Xiaobo Xu, Xiao Li, Yanli Li, Guobing Liu, Hui Tan, Hua Shen, Hongcheng Shi, Dengfeng Cheng   +8 more
doaj   +1 more source

Radioimmunotherapy Improves Survival of Rats with Microscopic Liver Metastases of Colorectal Origin [PDF]

, 2009
BACKGROUND: Half of the patients with colorectal cancer develop liver metastases during the course of their disease. The aim of the present study was to assess the efficacy of radioimmunotherapy (RIT) with a radiolabeled monoclonal antibody (mAb) to ...
Gabie M. de Jong, Thijs Hendriks, Annemarie Eek, Wim J. G. Oyen, Sandra Heskamp, Robert P. Bleichrodt, Otto C. Boerman, A Jemal, DM Parkin, J Scheele, KW Millikan, S Bipat, CG Moertel, TM Behr, RD Blumenthal, MJ Koppe, F Aarts, TM Behr, MS Zedeck, MJ Koppe, M Hagenaars, M Hagenaars, GM Jong, AM Lopes Cardozo, DM Goldenberg, GA Wiseman, TM Behr, MJ Koppe, TM Behr, RK Jain, AH Brouwers, F Aarts, F Aarts, MJ Koppe   +33 more
core   +1 more source

Comparison of I-131 Radioimmunotherapy Tumor Dosimetry: Unit Density Sphere Model Versus Patient-Specific Monte Carlo Calculations [PDF]

, 2011
High computational requirements restrict the use of Monte Carlo algorithms for dose estimation in a clinical setting, despite the fact that they are considered more accurate than traditional methods.
Bolch WE, Cristy M, David M. Howard, Hartmann Siantar CL, Kimberlee J. Kearfott, Loevinger R, Prestwich WV, Schipper MJ, Scott J. Wilderman, Sgouros G, Stabin MG, Stabin MG, Yoriyaz H, Yuni K. Dewaraja   +13 more
core   +1 more source

RADIOIMMUNOTHERAPY IN THE TREATMENT OF MALIGNANCIES

Сибирский онкологический журнал, 2016
This review presents information about one of the promising areas of targeted therapy in modern oncology, which is called radioimmunotherapy. Particular attention is paid to the possibility of clinical application of this type of systemic treatment for ...
V. I. Chernov, O. D. Bragina, I. G. Sinilkin, A. A. Titskaya, R. V. Zelchan   +4 more
doaj   +1 more source